Order of the Supreme Court of India in the matter of Network of People Living With HIV/AIDS & Others Vs Union of India & Others dated 24/02/2025. The Supreme Court (SC), February 24, 2025 has directed all states to file their affidavits addressing concerns raised about antiretroviral therapy (ART) drugs …
New Delhi : In an article printed this week, British Medical Journal has raised questions about the safety of a class of “new-age” drugs touted not only as a wonder cure for type 2 diabetes but also hailed for its possible potential as a weight loss agent. The BMJ article …
The World Health Organization has, for the first time in 40 years, issued interim guidance for the use of a new Tuberculosis drug — Bedaquiline. The drug was granted approval by the US Food and Drug Administration (FDA) last year. As per a press statement issued by the WHO on …
WHO estimates that up to half a million new cases of multidrug-resistant tuberculosis (MDR-TB) occur worldwide, each year. Current treatment regimens for MDR-TB present many challenges: treatment lasts 20 months or more, requiring daily administration of drugs that are more toxic, less effective, and far more expensive than those used …
A candidate drug, which acts in a novel way, has shown promising results in the laboratory against advanced prostate cancer that was insensitive to reduced levels of male sex hormones, according to a paper published in Nature Communications journal. Prostate cancers initially tend to be sensitive to male sex hormones, …
NEW DELHI: The government issued new guidelines on Thursday that require India's drugs companies to comply with the Good Manufacturing Practice (GMP) standards of the European Union to ensure pharmaceuticals exports to the 27-country region continue unrestricted. The directive, which will become effective from July 2, prescribes standards for the …
New York: A pill that can mimic the beneficial effects of calorie restriction may help prevent brain aging and even prolong life span, a new study has claimed. Previous studies have suggested that sharply reducing calorie intake, by as much as 40% could slow aging in cells and may even …
After bandying its Rs 6,000-crore a year scheme to provide free generic drugs at government health centres and hospitals for a year, the health ministry has now shelved the plan. The reasons are financial constraints and its inability to get in place a drug procurement policy in the last 18 …
50 cases detected in state in past few years, patients put on high-level medication More than 50 multi-drug resistant tuberculosis (MDR-TB) cases have been detected in the state in the past few years and the patients have been put on high-level medication. Though the state has a full-fledged anti-TB wing …
Drugs (Prices Control) Order, 2013 has directions to manufacturers of active pharmaceutical ingredients or bulk drugs or formulations and it states that the Government may, - with a view to achieve adequate availability and to regulate the distribution of drugs, in case of emergency or in circumstances of urgency or …
State Wants Proactive Role In Monitoring Trials Jaipur: At least one person, on an average, died every month in Rajasthan during clinical trials in the past eight years. But the state government had no clue about these trials and the related deaths. The figures for 2005-2012 came to light when …
291 cases of serious adverse events reported Drug trials on humans in Rajasthan over the last eight years have claimed 95 lives, while 291 persons experienced serious adverse events, according to the State government's latest deposition before the Supreme Court in an ongoing public interest litigation. While informing the apex …
Scheme To Be Launched From July 15, Will Cover 9 To 18-Yr-Olds New Delhi: Alarmed at the results of a survey of government school students that found 20% of them suffering from anaemia, Delhi government is set to launch Centre’s WIFS (Weekly Iron and Folic acid Supplementation programme) in all …
In many parts of the world, livestock production is undergoing a process of rapid intensification. The health implications of this development are uncertain. Intensification creates cheaper products, allowing more people to access animal-based foods. However, some practices associated with intensification may contribute to zoonotic disease emergence and spread, for example …
A PGI study has revealed the incidence of multi-drug resistant tuberculosis (MDRTB) in the Northern region is much higher than the WHO estimates. The study, which was published in the BMC infectious diseases journal in March this year, has found that the incidence of the MDRTB is 9 per cent …
Move to ensure compliance with recent guidelines; discrepancies to attract severe action The country's apex drug regulator plans periodic inspection of clinical trial sites to ensure these comply with the recently issued guidelines. If discrepancies are found, strict action is to be taken against the company and the trials might …
A report submitted to the State Human Rights Commission (SHRC) by the Drugs and Food Control Organisation (DFCO), a state government agency, has revealed that 438 medicines, including inject-able drugs have been found ‘not of standard quality’ (NSQ) after analysis over the past seven years. These samples were lifted randomly …
Some Private Hospitals Come Under Attack From Govt-Appointed Panel Thiruvananthapuram: The committee appointed by the government to look into the human drug trials has found that several companies in the state are conducting trials with just profit as their motive. To regulate this, the committee headed by Kerala State Council …
The World Health Organisation (WHO) has identified anti- malarial resistance in four countries of South East Asia and launched an emergency response to prevent resistant strains of the malarial parasites from spreading further. On the occasion of World Malaria Day today, the WHO has also cited concerns over resistance emerging …
As many as 2,644 people, called subjects, died during the clinical trials of 475 new drugs on human beings in last seven years and only 17 of the medicines were approved for marketing in India, the Centre has informed the Supreme Court. Responding to allegations by NGO, Swasthya Adhikar Manch, …
It's double trouble for global pharma companies in India. On April 1, a Supreme Court bench comprising Judges Aftab Alam and Ranjana Desai dismissed Swiss drug major Novartis AG's seven-year-old plea seeking patent protection for its blood cancer drug Imatinib Mesylate, sold as Glivec. The court held that Glivec was …
